I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?

Biology/Immunity Vaccines

A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…